1. 2363 Sorafenib plus Doxorubicin versus Sorafenib alone for advanced hepatocellular carcinoma (Soradox trial): final results of a prospective, randomized, open-label, multicenter phase IIb trial. (September 2015) Authors: Ettrich, T.; Perkofer, L.; Berger, A.W.; Güthle, M.; Behl, S.; Zipprich, A.; Wörns, M.A.; Waldschmidt, D.T.; Belle, S.; Michl, P.; Seufferlein, T.; Dollinger, M.M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Regorafenib improves survival after sorafenib in patients with recurrent HCC after liver transplantation. (March 2021) Authors: Iavarone, M.; Invernizzi, F.; Ivanics, T.; Mazza, S.; Zavaglia, C.; Sanduzzi-Zamparelli, M.; Fraile-López, M.; Czauderna, C.; Costanzo, G. Di; Bhoori, S.; Pinter, M.; Manini, M.A.; Amaddeo, G.; Yunquera, A. Fernandez; Piñero, F.; Rodríguez, M.J. Blanco; Anders, M.; Soteras, G. Aballay; Villadsen,... Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and effectiveness of Regorafenib in recurrent HCC after liver transplantation and progression on Sorafenib: a real-life multicentre study. (February 2019) Authors: Invernizzi, F.; Iavarone, M.; Czauderna, C.; Sanduzzi-Zamparelli, M.; Bhoori, S.; Amaddeo, G.; Manini, M.A.; López, M.F.; Anders, M.; Pinter, M.; Rodríguez, M.J. Blanco; Cristóbal, M.R.; Soteras, G.A.; Piñero, F.; Villadsen, G.E.; Weinmann, A.; Crespo, G.; Mazzaferro, V.; Regnault, H.; De Giorgio... Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗